NMPA Approval

Recombinant human interferon beta-1b for injection

Approval Number

国药准字SJ20130094

Registration Date

August 24, 2023

Previous Approval Numbers

S20130094

Drug Information

Generic Name

注射用重组人干扰素β-1b

Trade Name

倍泰龙

Dosage Form

注射剂

Strength

0.3mg/支

Drug Type

生物制品

Registration Date

August 24, 2023

Expiry Date

August 23, 2028

Company NameBAYER AG

Company Address

51368 Leverkusen, Germany

Company Address

Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

注射用重组人干扰素β-1b - NMPA 批准文号 | MedPath